Pure Global AI
Registration holder profile

GENESE PRODUTOS DIAGNOSTICOS LTDA

Brazil45 ANVISA registrations30 unique technical categoriesMay 06, 1999 – Apr 20, 2015
Verified
45
Total products
30
Technical names
May 1999
Earliest registration
Apr 2015
Latest registration
Regulatory footprint
Search GENESE PRODUTOS DIAGNOSTICOS LTDA across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this holder
ANTI-INSULIN ANTIBODY
INSULINA AB V3
Class II · Apr 20, 2015
Instrument intended for immunoassays
IMMUNOMAT BASE/BASEPLUS/TWINSYSTEM
Class II · Jul 28, 2014
Instrument for cell and platelet analysis or counting
Analisador de qualidade de esperma
Class II · Jul 14, 2014
ANTI-MICROSOMAL ANTIBODIES
AUTOANTICORPOS RECEPTORES DE TIREOTROPINA (TRAb)
Class II · Jun 02, 2014
1-25 DIHYDROXYVITAMIN D3 OF VITAMIN D
1,25 (OH)² Vitamina D
Class II · Apr 22, 2014
Most popular products
Products with most registrations
CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)
5 registrations
INHIBIN
3 registrations
17-HYDROXYPROGESTERONE (17-OHP)
3 registrations
DEHYDROEPIANDROSTERONE (DHEA)
3 registrations
ANTI-INSULIN ANTIBODY
2 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
DIASOURCE IMMUNOASSAY SA
10 products
DIASOURCE IMMUNOASSAYS S.A.
5 products
IMMUNOTECH A.S.
5 products
DIASOURCE IMMUNOASSAYS S.A
4 products
RSR LIMITED
3 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I3Distinct Products · 3 total registrations
Class II41Distinct Products · 42 total registrations
About this profile

Access comprehensive registration holder profile for GENESE PRODUTOS DIAGNOSTICOS LTDA through Pure Global AI's free Brazil medical device database. This registration holder manages 45 medical device registrations with ANVISA across 30 unique technical categories. Their regulatory portfolio spans from May 06, 1999 to Apr 20, 2015.

This page provides comprehensive insights including 5 recent product registrations with the latest being ANTI-INSULIN ANTIBODY (INSULINA AB V3), 5 most popular products led by CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES) with 5 registrations, partnerships with 5 key manufacturers including DIASOURCE IMMUNOASSAY SA and DIASOURCE IMMUNOASSAYS S.A., and products across 2 risk classifications with 3 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.